Abstract

Active machine learning is an experimental design approach that puts machine learning models in the driver seat of data acquisition and automated optimization. Introduced to drug discovery approximately 15 years ago, a handful of impressive studies have revealed the potential of active machine learning to guide molecular discovery and optimization. Most recently, researchers have shown that active learning can also be applied to datasets retrospectively, enabling automated data curation to train powerful machine learning models on small datasets. This chapter reviews the key findings from these active learning studies and summarizes remaining challenges and future opportunities of active learning as an adaptive learning technology in the context of drug discovery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.